Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca receives approval in the EU for Qtern (saxagliptin and dapagliflozin) for treatment of Type 2 diabetes
-
Tagrisso met primary endpoint in phase III 2nd-line lung cancer trial
-
AstraZeneca enters licensing agreements with LEO Pharma in skin diseases
-
New antibiotic Zavicefta approved in the European Union for patients with serious bacterial infections
-
AstraZeneca provides update on Flumist Quadrivalent Vaccine in the US for the 2016-17 influenza season
-
AstraZeneca enters commercialisation agreement with Aspen for anaesthetic medicines portfolio
-
AstraZeneca and Foundation Medicine enter strategic collaboration for Lynparza companion diagnostic assay
-
AstraZeneca completes US licensing agreement with Ironwood Pharmaceuticals for lesinurad
-
AstraZeneca licenses Zurampic to Grünenthal GmbH in Europe and Latin America
-
AstraZeneca’s Faslodex met primary endpoint in first-line treatment of advanced breast cancer
Latest articles and press releases
All of our latest press releases and articles are available to explore
